NuGenerex Immuno-Oncology, Inc. is an oncology company focuses on the modulation of the immune system to treat cancer. It develops immunotherapeutic products and vaccines based on proprietary, patented platform technology, Ii-Key. The Ii-Key is a peptide derived from the major histocompatibility complex (MHC) class II associated invariant chain that regulates the formation, trafficking, and antigen-presenting functions of MHC class II complexes, essential for the activation of T cells in the immune response. The company was founded on October 8, 1993 and is headquartered in Miramar, FL.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is the 52-week high for NuGenerex Immuno-Oncology Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. NuGenerex Immuno-Oncology Inc 52 week high is $0.30 as of September 06, 2025.
What is the 52-week low for NuGenerex Immuno-Oncology Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. NuGenerex Immuno-Oncology Inc 52 week low is $0.00 as of September 06, 2025.
What is NuGenerex Immuno-Oncology Inc stock price today?
NuGenerex Immuno-Oncology Inc stock price today is $0.0001.
What was NuGenerex Immuno-Oncology Inc stock price yesterday?
NuGenerex Immuno-Oncology Inc stock price yesterday was $0.0001.
What is the 50-day moving average of NuGenerex Immuno-Oncology Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. NuGenerex Immuno-Oncology Inc 50-day moving average is $0.0152.